Microbial Metabolite Dysbiosis and Colorectal Cancer

Gut Liver. 2023 Mar 15;17(2):190-203. doi: 10.5009/gnl220260. Epub 2023 Jan 12.

Abstract

The global burden of colorectal cancer (CRC) is expected to continuously increase. Through research performed in the past decades, the effects of various environmental factors on CRC development have been well identified. Diet, the gut microbiota and their metabolites are key environmental factors that profoundly affect CRC development. Major microbial metabolites with a relevance for CRC prevention and pathogenesis include dietary fiber-derived short-chain fatty acids, bile acid derivatives, indole metabolites, polyamines, trimethylamine-N-oxide, formate, and hydrogen sulfide. These metabolites regulate various cell types in the intestine, leading to an altered intestinal barrier, immunity, chronic inflammation, and tumorigenesis. The physical, chemical, and metabolic properties of these metabolites along with their distinct functions to trigger host receptors appear to largely determine their effects in regulating CRC development. In this review, we will discuss the current advances in our understanding of the major CRC-regulating microbial metabolites, focusing on their production and interactive effects on immune responses and tumorigenesis in the colon.

Keywords: Colonic neoplasms; Inflammation; Intestine; Microbial metabolites; Microbiome.

Publication types

  • Review

MeSH terms

  • Carcinogenesis
  • Cell Transformation, Neoplastic
  • Colorectal Neoplasms* / etiology
  • Colorectal Neoplasms* / prevention & control
  • Dysbiosis / complications
  • Humans
  • Intestines